NewsBenzingaKALA Bio (KALA)-Aktien steigen nachbörslich um 57 %: Darum KALA Bio (KALA)-Aktien steigen nachbörslich um 57 %: Darum Benzinga 2026.09.30 05:17 (GMT+0) Open on Benzinga Other news AbbVie Says All Three Zumilokibart Dose Regimens Met Primary Endpoint With Significantly Greater EASI-75 Response Vs Placebo At Week 16 In Phase 2 APEX Part B Atopic Dermatitis Study Capital One Financial Earnings Preview: What to Expect Takeda Presents Phase 3 Data Showing Once-Daily Oral Zasocitinib Delivers Higher PASI 100 At 36.5% Vs 13.9% And PASI 90 At 62.5% Vs 34.0% Than Deucravacitinib At Week 16; Under FDA, EMA Review For Plaque Psoriasis Redwire Teams Up With Sophia Space To Pair Deployable Systems And Integration Expertise With TILE Architecture For Scalable Orbital Data Centers AT&T CEO Challenges Elon Musk’s Starlink Cellular Plan, Says There Are ‘A Whole Bunch Of Reasons’ Why SPCX’s Strategy Won’t Work — ‘Nothing Beats’ Fiber Robinhood Unveils In-App AI Agents for Crypto and Stock Trading
AbbVie Says All Three Zumilokibart Dose Regimens Met Primary Endpoint With Significantly Greater EASI-75 Response Vs Placebo At Week 16 In Phase 2 APEX Part B Atopic Dermatitis Study
Takeda Presents Phase 3 Data Showing Once-Daily Oral Zasocitinib Delivers Higher PASI 100 At 36.5% Vs 13.9% And PASI 90 At 62.5% Vs 34.0% Than Deucravacitinib At Week 16; Under FDA, EMA Review For Plaque Psoriasis
Redwire Teams Up With Sophia Space To Pair Deployable Systems And Integration Expertise With TILE Architecture For Scalable Orbital Data Centers
AT&T CEO Challenges Elon Musk’s Starlink Cellular Plan, Says There Are ‘A Whole Bunch Of Reasons’ Why SPCX’s Strategy Won’t Work — ‘Nothing Beats’ Fiber
